RTW INVESTMENTS, LP - Q3 2014 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2014
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ALNYLAM PHARMACEUTICALS INC37Q4 202319.7%
MASIMO CORP35Q2 20245.8%
REGENXBIO INC32Q2 202410.8%
PTC THERAPEUTICS INC31Q2 202412.8%
LA JOLLA PHARMACEUTICAL CO31Q2 20229.7%
AGENUS INC29Q2 20229.0%
ARGENX SE29Q2 20245.3%
DICERNA PHARMACEUTICALS INC28Q3 202110.8%
MIRATI THERAPEUTICS INC27Q4 20236.2%
VERICEL CORP27Q2 20243.9%

View RTW INVESTMENTS, LP's complete holdings history.

Latest significant ownerships (13-D/G)
RTW INVESTMENTS, LP Q3 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
89bio, Inc.February 14, 20245,578,9316.0%
ACADIA PHARMACEUTICALS INCFebruary 14, 202411,253,5516.9%
Adicet Bio, Inc.February 14, 20244,134,6319.6%
Akero Therapeutics, Inc.February 14, 20243,592,7596.4%
Apyx Medical CorpFebruary 14, 20241,025,9633.0%
ARVINAS, INC.February 14, 20244,213,4836.2%
AVADEL PHARMACEUTICALS PLCFebruary 14, 20249,196,18610.0%
Axsome Therapeutics, Inc.February 14, 20244,489,5969.5%
Brainsway Ltd.Sold outFebruary 14, 202400.0%
C4 Therapeutics, Inc.Sold outFebruary 14, 202400.0%

View RTW INVESTMENTS, LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-08-23
N-PX2024-08-22
13F-HR2024-08-14
SC 13D/A2024-08-07
SC 13D/A2024-07-02
13F-HR2024-05-15
SC 13D/A2024-04-17
SC 13D/A2024-03-01
13F-HR2024-02-14
SC 13G/A2024-02-14

View RTW INVESTMENTS, LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export RTW INVESTMENTS, LP's holdings

CSVXLS